The late Canadian novelist Robertson Davies once remarked that the eye sees only what the mind is prepared to comprehend. He could almost have been referring to oft-reported negative experiences of patients switching from branded to generic drugs.
But look beyond the shiny packaging - branded drugs are biochemically the same as generic equivalents. Both have the same active ingredient, delivered to the body in the same way. Both have the same effects, according to an article posted today on the website of New Zealand’s Pharmaceutical Management Agency PHARMAC.
Auckland University’s Keith Petrie is one of New Zealand’s experts in health psychology. He says low patient expectations about generics are largely explained by perception and unconscious brand bias. Feedback from others, including fellow patients, and availability of choice can also influence patients’ assessment of a medication’s effectiveness.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze